13D Filing: Bain Capital Life Sciences Fund, L.p. and Dicerna Pharmaceuticals Inc (NASDAQ:DRNA)

Page 3 of 12

Page 3 of 12 – SEC Filing


CUSIP No. 253031108 13D Page
3

of 12
  1 

Names of
Reporting Persons

BCIP Life Sciences Associates, LP

  2

Check the Appropriate Box if a Member
of a Group

(a)  ☐        (b)  ☐

  3

SEC Use Only

  4

Source of Funds

WC

  5

Check if Disclosure of Legal
Proceedings is Required Pursuant to Item 2(d) or 2(e)  ☐

  6

Citizenship or Place of
Organization

Delaware

Number of

Shares

Beneficially

Owned by

Each

Reporting

Person

With

  7 

Sole Voting Power

747,993 shares of Common Stock

  8

Shared Voting Power

0 shares of Common Stock

  9

Sole Dispositive Power

747,993 shares of Common Stock

10

Shared Dispositive Power

0 shares of Common Stock

11

Aggregate Amount Beneficially Owned by Each Reporting Person

747,993 shares of Common Stock

12

Check if the Aggregate Amount in Row
(11) Excludes Certain Shares  ☐

13

Percent of Class Represented by Amount
in Row (11)

3.5%

14

Type of Reporting Person

PN

Follow Dicerna Pharmaceuticals Inc (NASDAQ:DRNA)

Page 3 of 12